ATE195711T1 - Tetrahydroindenol(1,2-d)(1,3,2)oxazaborole und deren verwendung als enantioselektive katalysatoren - Google Patents

Tetrahydroindenol(1,2-d)(1,3,2)oxazaborole und deren verwendung als enantioselektive katalysatoren

Info

Publication number
ATE195711T1
ATE195711T1 AT95921397T AT95921397T ATE195711T1 AT E195711 T1 ATE195711 T1 AT E195711T1 AT 95921397 T AT95921397 T AT 95921397T AT 95921397 T AT95921397 T AT 95921397T AT E195711 T1 ATE195711 T1 AT E195711T1
Authority
AT
Austria
Prior art keywords
tetrahydroindenol
oxazaborols
iii
oxazaboroles
indanols
Prior art date
Application number
AT95921397T
Other languages
English (en)
Inventor
Yun Gao
Yaping Hong
Charles M Zepp
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of ATE195711T1 publication Critical patent/ATE195711T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
AT95921397T 1994-05-31 1995-05-24 Tetrahydroindenol(1,2-d)(1,3,2)oxazaborole und deren verwendung als enantioselektive katalysatoren ATE195711T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/250,821 US5495054A (en) 1994-05-31 1994-05-31 Tetrahydroindeno[1,2-D][1,3,2]oxazaboroles and their use as enantioselective catalysts
PCT/US1995/006615 WO1995032937A1 (en) 1994-05-31 1995-05-24 TETRAHYDROINDENO[1,2-d][1,3,2]OXAZABOROLES AND THEIR USE AS ENANTIOSELECTIVE CATALYSTS

Publications (1)

Publication Number Publication Date
ATE195711T1 true ATE195711T1 (de) 2000-09-15

Family

ID=22949300

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95921397T ATE195711T1 (de) 1994-05-31 1995-05-24 Tetrahydroindenol(1,2-d)(1,3,2)oxazaborole und deren verwendung als enantioselektive katalysatoren

Country Status (12)

Country Link
US (1) US5495054A (de)
EP (1) EP0763005B1 (de)
JP (1) JP3867250B2 (de)
AT (1) ATE195711T1 (de)
AU (1) AU689595B2 (de)
CA (1) CA2191073C (de)
DE (1) DE69518516T2 (de)
DK (1) DK0763005T3 (de)
ES (1) ES2149991T3 (de)
GR (1) GR3034809T3 (de)
PT (1) PT763005E (de)
WO (1) WO1995032937A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69512002T2 (de) * 1994-10-28 2000-05-25 Sumitomo Chemical Co Verfahren zur Herstellung von optisch aktiven Carbinolen
JP3665343B2 (ja) * 1995-02-03 2005-06-29 株式会社カネカ α−ハロケトン、α−ハロヒドリン及びエポキシドの製造法
JPWO2002051781A1 (ja) * 2000-12-25 2004-04-22 味の素株式会社 光学活性ハロヒドリン化合物の製造方法
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
BRPI0509382A (pt) * 2004-04-02 2007-09-18 Glaxo Group Ltd processo para a preparação de um sal monocloridrato de composto, monocloridrato cristalino, processo para obter monocloridrato cristalino, método para a profilaxia ou o tratamento de uma condição clìnica em um mamìfero, uso de monocloridrato cristalino, formulação farmacêutica, e, combinação
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
UY30550A1 (es) 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
CN101747211A (zh) * 2009-07-03 2010-06-23 凯莱英生命科学技术(天津)有限公司 一种手性β-氨基醇衍生物的合成方法及其部分最终产物
WO2011132083A2 (en) 2010-04-20 2011-10-27 Actavis Group Ptc Ehf Novel process for preparing phenylcyclopropylamine derivatives using novel intermediates
CN110627673B (zh) * 2018-06-22 2023-04-07 上海天慈中商药业有限公司 一种福莫特罗关键中间体的制备方法
CN109748788B (zh) * 2019-01-17 2021-05-14 南方科技大学 ɑ-羟基酸制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943635A (en) * 1987-08-27 1990-07-24 President & Fellows Of Harvard College Enantioselective reduction of ketones
US5039802A (en) * 1990-04-18 1991-08-13 Merck & Co., Inc. Arylation process for preparation of chiral catalysts for ketone reduction
US5264585A (en) * 1990-04-18 1993-11-23 Merck & Co., Inc. Chiral catalysts for reduction of ketones and process for their preparation
US5189177A (en) * 1990-04-18 1993-02-23 Merck & Co., Inc. Chiral boron catalysts for reduction of ketones and process for their preparation
US5157129A (en) * 1990-04-18 1992-10-20 Merck & Co., Inc. Enantiospecific synthesis of s-(+)-5,6-dihydro-4-(r-amino)-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide
WO1993023408A1 (en) * 1992-05-14 1993-11-25 Pfizer Inc. Enantioselective oxazaborolidine catalysts
TW416958B (en) * 1993-05-14 2001-01-01 Pfizer Enantioselective oxazaborolidine catalysts

Also Published As

Publication number Publication date
AU689595B2 (en) 1998-04-02
JP3867250B2 (ja) 2007-01-10
EP0763005B1 (de) 2000-08-23
JPH10501530A (ja) 1998-02-10
GR3034809T3 (en) 2001-02-28
CA2191073C (en) 2007-07-17
AU2648795A (en) 1995-12-21
DE69518516T2 (de) 2001-04-19
EP0763005A4 (de) 1997-10-22
EP0763005A1 (de) 1997-03-19
CA2191073A1 (en) 1995-12-07
DE69518516D1 (de) 2000-09-28
DK0763005T3 (da) 2000-12-27
WO1995032937A1 (en) 1995-12-07
ES2149991T3 (es) 2000-11-16
PT763005E (pt) 2001-01-31
US5495054A (en) 1996-02-27

Similar Documents

Publication Publication Date Title
ATE195711T1 (de) Tetrahydroindenol(1,2-d)(1,3,2)oxazaborole und deren verwendung als enantioselektive katalysatoren
DE69715466T2 (de) Verwendung eines fermenters
MY111215A (en) Enantioselective oxazaborolidine catalysts
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE59808710D1 (de) Verfahren zur herstellung von 2-(3-pyrazolyl-oxymethylen)nitrobenzolen
AU2612299A (en) A fluorescence polarization screening method
ATE332356T1 (de) Verwendung von metallkomplexverbindungen als oxidationskatalysatoren
DE59305855D1 (de) 5-Oxo-dibenzo[a,d]cyclohepta-1,4-diene und ihre Verwendung als retrovirale Mittel
EP0855418A3 (de) Hochreine, verzweigte, flüssige Phenylsiloxane
DE59813294D1 (de) Verfahren zur Herstellung von Formylimidazolen
ATE168692T1 (de) 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69943259D1 (de) Neue 2-Halogen-Derivate von 5-O-Desosaminylerythronolid A, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
AU550964B2 (en) Pyrido(1,4)benzodiazepines and (2-((nitro-pyridinyl) amino) phenyl) arylmethanone precursors
DE69711506T2 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ATE266670T1 (de) 1,3-diphenylphosphinopropan-liganden und entsprechende übergangsmetallkomplexe, deren herstellung und verwendung
TW270112B (en) Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates
Mcdowell A general formula for estimation of the rate of transport of non-cohesive bed-load
DE59602931D1 (de) Wasserfreies Trinatriumcitrat, Verfahren zu seiner Herstellung und seine Verwendung als Trägermaterial
ATE76639T1 (de) Neue dopamin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES288242U (es) Agenda perfeccionada

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification